Download PDF
Zentralbl Chir 2006; 131(3): 210-216
DOI: 10.1055/s-2006-933472
Originalarbeiten und Übersichten

© Georg Thieme Verlag Stuttgart · New York

Strategie des chirurgischen Vorgehens beim hilären Cholangiokarzinom

Surgical Approach in Hilar CholangiocarcinomaG. Otto1
  • 1Abteilung für Transplantationschirurgie/Chirurgie von Leber, Gallenwegen und Pankreas der Johannes-Gutenberg-Universität Mainz
Further Information

Publication History

Publication Date:
31 May 2006 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die Operation ist die entscheidende lebensverlängernde Therapie des hilären Cholangiokarzinoms. Das chirurgische Vorgehen beruht auf retrospektiven Analysen. Da die Prognose nicht resezierter Patienten nur etwa 6 Monate beträgt, ist das Erzielen einer hohen Resektionsrate entscheidend. Die hierfür erforderliche diagnostische Abklärung des longitudinalen Tumorwachstums gelingt am besten durch perkutane transhepatische Cholangiographie. Im Ergebnis der Diagnostik wird die Tumorausdehnung eher über- als unterschätzt. Die Resektion sollte als en-bloc-Resektion von Tumor und Leber erfolgen. Unsicher ist, ob Art der Leberresektion, Umfang der Lymphadenektomie und die prinzipielle Mitresektion von Gefäßen die Prognose beeinflussen. Die Patienten im eigenen Krankengut überlebten nach Resektion 813, nach explorativer Laparotomie im Median 214 Tage. Die Resektionsrate betrug 71 %, die Rate kurativer Resektionen 72 %, die Operationsletalität 7 %. In der multivariaten Analyse war der Lymphknotenbefall der einzige signifikante prognostische Parameter.

Abstract

Surgery is the decisive life-prolongating treatment in patients with hilar cholangiocarcinoma. Surgery is mainly based on empiric data. Since patients without surgery have only about 6 months to survive, to achieve a high resection rate is crucial for these patients. During diagnostic workup, percutaneous transhepatic cholangiography results in the most reliable assessment of longitudinal tumor growth. The extent of the tumor is frequently overestimated leading to the consequence of exluding the patients from surgery. En-bloc resection of the tumor and the adjacent liver should be the preferred surgical approach. So far, surgical radicality (right trisegmentectomy, extended lymphadenectomy and vascular resection) has not been demonstrated to prolong survival. In our experience with 117 patients, median survival of patients following resection was 813 days, whereas patients not amenable to resection survived for 214 days only. Resection rate and the rate of curative resections were 71 and 72 %, respectively, operative mortality was 7 %. In the multivariate analysis, lymph node involvement proved to be the only prognostic marker.

Schlüsselworte

hiläres Cholangiokarzinom - Resektion - Diagnostik - Prognose

Key words

hilar cholangiocarcinoma - surgery - diagnosis - prognosis

Literatur

  • 1 Altehoefer C, Ghanem N, Furtwangler A, Schneider B, Langer M. Breathhold unenhanced and gadolinium-enhanced magnetic resonance tomography and magnetic resonance cholangiography in hilar cholangiocarcinoma.  Int J Colorectal Dis. 2001;  16 188-192
    CrossrefPubMedGoogle Scholar
  • 2 Capussotti L, Muratore A, Polastri R, Ferrero A, Massucco P. Liver resection for hilar cholangiocarcinoma. In-hospital martality and longterm survival.  J Am Coll Surg. 2002;  195 641-647
    CrossrefPubMedGoogle Scholar
  • 3 Dimick J B, Wainess R M, Cowan J A, Upchurch Jr  G R, Knol J A, Colletti L M. National trends in the use and outcomes of hepatic resection.  J Am Coll Surg. 2004;  199 31-38
    PubMedGoogle Scholar
  • 4 Ebata T, Nagino M, Kamiya J, Uesaka K, Nagasaka T, Nimura Y. Hepatectomy with portal vein resection for hilar cholangiocarcinoma. Audit of 52 consecutive cases.  Ann Surg. 2003;  238 720-727
    CrossrefPubMedGoogle Scholar
  • 5 Figueras J, Llado L, Valls C, Serrano T, Ramos E, Fabregat J, Rafecas A, Torras J, Jaurrieta E. Changing strategies in diagnosis and management of hilar cholangiocarcinoma.  Liver Transpl. 2001;  6 786-794
    PubMedGoogle Scholar
  • 6 Fritscher-Ravens A, Broering D C, Knoefel W T, Rogiers X, Swain P, Thonke F, Bobrowski C, Topalidis T, Soehendra N. EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology.  Am J Gastroenterol. 2004;  99 45-51
    CrossrefPubMedGoogle Scholar
  • 7 Gerhards M F, van Gulik T M, Gonzalez Gonzalez D, Rauws E A, Gouma D J. Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma.  World J Surg. 2003;  27 173-179
    PubMedGoogle Scholar
  • 8 Gerhards M F, van Gulik T M, de Wit L T, Obertop H, Gouma D J. Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma. A single center experience.  Surgery. 2000;  127 395-404
    CrossrefPubMedGoogle Scholar
  • 9 Gerhards M F, Vos P, van Gulik T M, Rauws E A, Bosma A, Gouma D J. Incidence of benign lesions in patients resected for suspicious hilar obstruction.  Br J Surg. 2001;  88 48-51
    CrossrefPubMedGoogle Scholar
  • 10 Golfieri R, Giampalma E, Muzzi C, Maffei M, Amore B, Grazia C, Frezza G, Galuppi A, Gavelli G. Unresectable hilar cholangiocarcinoma: combined percutaneous and radiotherapeutic treatment.  Radiol Med (Torino). 2001;  101 495-502
    PubMedGoogle Scholar
  • 11 Guthrie J A, Ward J, Robinson P J. Hilar cholangiocarcinomas. T2-weighted spin-echo and gadolinium-enhanced FLASH MR imaging.  Radiology. 1996;  201 347-351
    PubMedGoogle Scholar
  • 12 Han J K, Choi B I, Kim T K, Kim S W, Han M C, Yeon K M. Hilar cholangiocarcinoma. Thin-section spiral CT findings with cholangiographic correlation.  Radiographics. 1997;  17 1475-1485
    PubMedGoogle Scholar
  • 13 IJitsma A J, Appeltans B M, de Jong K P, Porte R J, Peeters P M, Slooff M J. Extrahepatic bile duct resection in combination with liver resection for hilar cholangiocarcinoma. A report of 42 cases.  J Gastrointest Surg. 2004;  8 686-694
    CrossrefPubMedGoogle Scholar
  • 14 Jarnagin W R, Fong Y, DeMatteo R P, Gonen M, Burke E C, Bodniewicz W R, Youssef B AM, Klimstra D, Blumgart L H. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.  Ann Surg. 2001;  234 507-517
    CrossrefPubMedGoogle Scholar
  • 15 Kaiho T, Miyazaki M, Ito H, Nakagawa K, Ambiru S, Shimizu H, Shimizu Y, Okuno A, Nozawa S, Nukui Y, Nakajima N. Treatment of unresectable hepatic hilar malignancies with self-expanding metallic stents.  Hepatogastroenterology. 1999;  46 2781-2790
    PubMedGoogle Scholar
  • 16 Kawarada Y, Das B C, Naganuma T, Tabata M, Taoka H. Surgical treatment of hilar bile duct carcinoma. Experience with 25 consecutive hepatectomies.  J Gastrointest Surg. 2002;  6 617-624
    CrossrefPubMedGoogle Scholar
  • 17 Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features.  Am J Med. 1965;  28 241-256
    PubMedGoogle Scholar
  • 18 Klempnauer J, Ridder G J, Wasielewski R von, Werner M, Weimann A, Pichlmayr R. Resectional surgery of hilar cholangiocarcinoma. A multivariate analysis of prognostic factors.  J Clin Oncol. 1997;  15 947-954
    PubMedGoogle Scholar
  • 19 Kitagawa Y, Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H, Hayakawa N, Nimura Y. Lymph node metastasis from hilar cholangiocarcinoma. Audit of 110 patients who underwent regional and paraaortic node dissection.  Ann Surg. 2001;  233 385-392
    CrossrefPubMedGoogle Scholar
  • 20 Kokudo N, Makuuchi M. Current role of portal vein embolization/hepatic artery chemoembolization.  Surg Clin North Am. 2004;  84 643-657
    CrossrefPubMedGoogle Scholar
  • 21 Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M. Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection.  Ann Surg. 1999;  230 663-671
    CrossrefPubMedGoogle Scholar
  • 22 Launois B, Reding R, Lebeau G, Buard J L. Surgery for hilar cholangiocarcinoma. French experience in a collective survey of 552 extrahepatic bile duct cancers.  J Hepatobiliary Pancreat Surg. 2000;  7 128-134
    CrossrefPubMedGoogle Scholar
  • 23 Lee S G, Lee Y J, Park K M, Hwang S, Min P C. One hundred and eleven liver resections for bile duct cancer.  J Hepatobiliary Pancreat Surg. 2000;  7 135-141
    CrossrefPubMedGoogle Scholar
  • 24 Lillemoe K D, Cameron J L. Surgery for hilar cholangiocarcinoma. The Johns Hopkins approach.  J Hepatobiliary Pancreat Surg. 2000;  7 115-121
    CrossrefPubMedGoogle Scholar
  • 25 Manfredi R, Brizi M G, Masselli G, Vecchioli A, Marano P. Malignant biliary hilar stenosis. MR cholangiography compared with direct cholangiography.  Radiol Med (Torino). 2001;  102 48-54
    PubMedGoogle Scholar
  • 26 Miyazaki M, Ito H, Nakagawa K, Ambiru S, Chimizu H, Chimizu Y, Akuno A, Nozawa S, Nukui Y, Yoshitomi H, Nakajiwa N. Aggressive surgical approaches to hilar cholangiocarcinoma. Hepatic or local resection?.  Surgery. 1998;  123 131-136
    CrossrefPubMedGoogle Scholar
  • 27 Miyazaki M, Ito H, Nakagawa K, Ambiru S, Shimizu H, Okaya T, Shinmura K, Nakajima N. Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma.  J Am Coll Surg. 1999;  189 575-583
    CrossrefPubMedGoogle Scholar
  • 28 Mizumoto R, Kawarada Y, Suzuki H. Surgical treatment of hilar carcinoma of the bile duct.  Surg Gynecol Obstet. 1986;  162 153-158
    PubMedGoogle Scholar
  • 29 Munoz L, Roayaie S, Maman D, Fishbein T, Seiner P, Emre S, Miller C. Hilar cholangiocarcinoma involving the portal vein bifurcation. Long-term results after resection.  J Hepatobiliary Pancreat Surg. 2002;  9 237-241
    CrossrefPubMedGoogle Scholar
  • 30 Nagino M, Nimura Y, Kamiya J, Kono S, Uesaka K, Kin Y, Kutsuna Y, Hayakawa N, Yamamoto H. Right or left portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma.  Surgery. 1995;  117 677-681
    PubMedGoogle Scholar
  • 31 Nagino M, Nimura Y, Kamiya J. et al . Preoperative management of hilar cholangiocarcinoma.  J Hepatobil Pancreat Surg. 1995;  2 215-223
    CrossrefPubMedGoogle Scholar
  • 32 Nagino M, Nimura Y, Kamiya J, Kanai M, Uesaka K, Hayakawa N, Yamamoto H, Kondo S, Nishio H. Segmental liver resections of hilar cholangiocarcinoma.  Hepato-Gastroenterology. 1998;  45 7-13
    PubMedGoogle Scholar
  • 33 Nakajima T, Kondo Y, Miyazaki M, Okui K. A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma. Histologic classification and modes of spreading.  Hum Pathol. 1988;  19 1228-1234
    PubMedGoogle Scholar
  • 34 Neuhaus P, Jonas S, Bechstein W O, Lohmann R, Radke C, Kling N, Wex C, Lobeck H, Hintze R. Extended resections for hilar cholangiocarcinoma.  Ann Surg. 1999;  230 808-819
    CrossrefPubMedGoogle Scholar
  • 35 Neuhaus P, Jonas S, Settmacher U, Thelen A, Benckert C, Lopez-Hanninen E, Hintze R E. Surgical management of proximal bile duct cancer. Extended right lobe resection increases resectability and radicality.  Langenbecks Arch Surg. 2003;  388 194-200
    CrossrefPubMedGoogle Scholar
  • 36 Nimura Y, Hayakawa N, Kamiya J. et al . Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus.  World J Surg. 1990;  14 535-543
    CrossrefPubMedGoogle Scholar
  • 37 Nimura Y, Kamiya J, Kondo S, Nagino M, Kanai M. Technique of inserting multiple biliary drains and management.  Hepato-Gastroenterology. 1995;  42 323-331
    PubMedGoogle Scholar
  • 38 Nimura Y, Kamiya J, Kondo S, Nagino M, Uesaka K, Oda K, Sano T, Yamamoto H, Hayakawa N. Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma. Nagoya experience.  J Hepatobiliary Pancreat Surg. 2000;  7 155-162
    CrossrefPubMedGoogle Scholar
  • 39 Ortner M E, Caca K, Berr F, Liebetruth J, Mansmann U, Huster D, Voderholzer W, Schachschal G, Mossner J, Lochs H. Successful photodynamic therapy for nonresectable cholangiocarcinoma. A randomized prospective study.  Gastroenterology. 2003;  125 1355-1363
    CrossrefPubMedGoogle Scholar
  • 40 Otto G, Romaneehsen B, Bittinger F, Mönch C, Thelen M, Hadian A, Lohse A W. Preoperative imaging of hilar cholangiocarcinoma: surgical evaluation of standard practises.  Z Gastroenterol. 2004;  42 9-14
    PubMedGoogle Scholar
  • 41 Otto G, Romaneehsen B, Hoppe-Lotichius M, Bittinger F. Hilar cholangiocarcinoma. Resectability and radicality after routine diagnostic imaging.  J Hepatobiliary Pancreat Surg. 2004;  11 310-318
    CrossrefPubMedGoogle Scholar
  • 42 Puhalla H, Gruenberger T, Pokorny H, Soliman T, Wrba F, Sponer U, Winkler T, Ploner M, Raderer U, Steininger R, Muhlbacher F, Laengle F. Resection of hilar cholangiocarcinomas. Pivotal prognostic factors and impact of tumor sclerosis.  World J Surg. 2003;  27 680-684
    CrossrefPubMedGoogle Scholar
  • 43 Takada T. Is preoperative drainage necessary according to evidence-based medicine?.  J Hepatobiliary Pancreat Surg. 2001;  8 58-64
    CrossrefPubMedGoogle Scholar
  • 44 Tillich M, Mischinger H J, Preisegger K H, Rabl H, Szolar D H. Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma.  Am J Roentgenol. 1998;  171 651-658
    PubMedGoogle Scholar
  • 45 Tojima Y, Nagino M, Ebata T, Uesaka K, Kamiya J, Nimura Y. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma.  Ann Surg. 2003;  237 201-207
    CrossrefPubMedGoogle Scholar
  • 46 Tsao J I, Nimura Y, Kamiya J, Hayakawa N, Kondo S, Nagino M, Miyachi M, Kanai M, Uesaka K, Oda K, Rossi R L, Braasch J W, Dugan J M. Management of hilar cholangiocarcinoma. Comparison of an American and Japanese experience.  Ann Surg. 2000;  232 166-174
    CrossrefPubMedGoogle Scholar
  • 47 Wiedmann M W, Berr R, Schiefke I, Witzigmann H, Kohlhaw K, Mossner J, Caca K. Photodynamic therapy in patients with non-resectable hilar cholangiocarcinoma. 5-year follow-up ot a prospective phase II study.  Gastrointest Endosc. 2004;  60 68-75
    CrossrefPubMedGoogle Scholar
  • 48 Yamashita Y, Takahashi M, Kanazawa S, Charnsangavej C, Wallace S. Parenchymal changes of the liver in cholangiocarcinoma. CT evaluation.  Gastrointest Radiol. 1992;  17 161-166
    CrossrefPubMedGoogle Scholar
  • 49 Zidi S H, Prat F, Le Guen O, Rondeau Y, Pelletier G. Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures.  Gut. 2000;  46 103-106
    CrossrefPubMedGoogle Scholar

Prof. Dr. G. Otto

Abteilung für Transplantationschirurgie/Chirurgie von Leber, Gallenwegen und Pankreas · Johannes-Gutenberg-Universität Mainz

Langenbeckstr. 1

55101 Mainz

Phone: +49/61 31/17 36 13

Fax: +49/61 31/17 55 54

Email: otto@transplantation.klinik.uni-mainz.de

      >